INTRODUCTION
Transgender people have a gender identity or expression that is inconsistent with their legal sex at birth [1,2]. Transgender individuals can be classified as transwoman, transman, non-binary transgender person, etc. Non-binary transgender people refer to those who do not identify themselves as either man or woman [3]. Unlike transgender individuals, cisgender people have a gender identity or expression that matches their legal sex at birth [4].
In the US, prevalence of the transgender population was estimated to be 390 per 100,000 individuals [5]. This estimation is based on a meta-analysis of 12 national surveys using three databases in 2017, so the results address problems in previous studies resulting from non-probability sampling and representativeness estimating the transgender population size. By extrapolating the estimated frequency of transgender individuals from the meta-analysis study to the total Korean population, which is 51,635,256 as of February 2018 [6], there are an estimated 201,377 transgender individuals in Korea.
Through gender transition, transgender people live their lives with the gender expression or presentation that affirms their gender identity [7]. When medically necessary, many transgender individuals undergo transition-related healthcare or medical transition, including gender identity disorder (GID) diagnosis, hormone therapy, and sex reassignment surgery [7]. Transition-related healthcare can alleviate gender dysphoria and improve physical and mental health as well as quality of life among transgender people [8-10]. Although not all transgender individuals receive hormone therapy or sex reassignment surgery [7,11], transition-related healthcare is a salient factor for transgender people’s health and wellbeing [4].
In Korea, access to transition-related healthcare is critical not only for reducing transgender individuals’ own gender dysphoria, but also for institutional factors, such as legal sex change and exemption from military service [7,11]. Legal sex change is based on “The Guidelines for the Handling of Petition for Legal Sex Change Permit of Transgender People” in Article 435 of the Supreme Court Family Relation Registration Regulation in Korea [12,13]. The regulation requires applicants to receive a psychiatric diagnosis of GID, remove reproductive capacity, and have sex reassignment surgery through investigative matters and compulsory documentation.
Further, all individuals whose legal sex is male and who have Korean nationality are obliged to serve in military services, as mandated by the Military Service Act and Article 39 (1) of the Constitution of Korea. This obligation also applies to transwomen who do not change their legal sex at birth [14,15]. Under such circumstances, transwomen who wish to be exempt from military service must obtain a GID diagnosis, receive hormone therapy, and even undergo sex reassignment surgery [11,14,15]. Transmen are also required to have a physical examination for military service after changing their legal sex to male [14].
However, the Korean healthcare system and policies related to transition-related healthcare are not well established [7,11]. Standard curricula for educating and training healthcare professionals do not include transition-related healthcare, and few training manuals or guidelines present this information. Further, transgender individuals are burdened with the entire cost of hormone therapy and sex reassignment surgery because those medical procedures are not covered by national health insurance.
Research on the experiences of and barriers to transition-related healthcare among transgender people is also lacking in Korea. Only 22 out of 128 studies on the health of lesbian, gay, bisexual, and transgender people that published before 2013 included trans2gender people, and most were case reports of transgender patients or clinical studies introducing methods for sex reassignment surgery [16]. Besides hospital-based clinical studies, research regarding the experiences of transition-related healthcare among transgender people is limited to only a single qualitative study in 2017 [11].
This study aimed to investigate the experiences of and barriers to transition-related healthcare, including GID diagnosis, hormone therapy, and sex reassignment surgery, for transgender adults in Korea. In addition, this study examined the experiences of non-prescribed hormone use and the reasons for that use to identify unsafe practices regarding transition-related healthcare among Korean transgender people.
MATERIALS AND METHODS
Data and study population
This study conducted a nationwide cross-sectional survey of Korean transgender adults to explore their experiences of transition-related healthcare and the barriers to those procedures. Participants were ≥19 years old and self-identified as either: 1) transwoman, 2) transman, or 3) non-binary transgender person with the experiences of transition-related healthcare. Because non-binary transgender people also undergo transition-related healthcare based on institutional factors as well as medical treatments for relieving gender dysphoria [11], they were also included in the study.
Data were collected through an online-based survey from June 27 to August 31, 2017. To advertise the survey and recruit study participants, this study utilized Korea Queer Festivals held in Seoul and Daegu, four healthcare institutions in Seoul that provide transition-related healthcare for transgender patients, and three online/offline transgender communities. Informed consent for participating in the survey and using the data for academic purposes was collected from all respondents. As compensation for participation, all respondents were rewarded 10,000 Korean won (KRW). This study protocol was approved by the institutional review board of Korea University (no. 1040548-KU-IRB-17-67-A-1).
A total of 347 transgender adults participated in the survey. Among them, there were 5 respondents who did not consent to academic use of the study, 62 respondents who did not provide demographic information including age and gender identity, and 2 respondents who did not respond to the question about GID diagnosis. After excluding those respondents, the final study population consisted of 278 transgender individuals.
Measurement
Questionnaires were used to collect information on the experiences of transition-related healthcare, access to healthcare, health status, etc. Participants answered approximately 160-230 questions, including several additional questions depending on their gender identity and experiences of transition-related healthcare.
Regarding respondents’ gender identity, this study assessed both legal sex at birth and current gender identity to classify those with mismatching legal sex at birth and current gender identity as transgender people and those with matching identities as cisgender people (Table 1) [17]. Among transgender respondents, those whose legal sex at birth was male and currently identifying as woman were classified as transwomen, whereas those whose legal sex at birth was female and currently identifying as man were classified as transmen. Respondents who identified as neither man nor woman were categorized as non-binary transgender people. In this study, non-binary transgender individuals and transwomen whose legal sex at birth were male were classified as transfeminine, whereas non-binary transgender individuals and transmen whose legal sex at birth were female were classified as transmasculine [4].
Age, sexual orientation, and residential area were collected as demographic characteristics. Age was dichotomized as 19-29 years or 30-50 years. Respondents’ sexual orientation was classified as homosexual, bisexual, heterosexual, or asexual. Residential area was categorized into three categories (Seoul metropolitan city, other metropolitan cities, or other cities and counties). Respondents also provided information on socioeconomic status, such as educational level (≤high school graduate, college graduate, university graduate, or ≥graduate school graduate), annual household income (<10,000,000, 10,000,000-19,990,000, 20,000,000-29,990,000, 30,000,000-49,990,000, or ≥50,000,000 KRW), and employment status (unemployed, non-precarious employment, precarious employment, self-employed, or unpaid family worker). In addition, respondents reported the route to participating in the survey.
We classified transition-related healthcare into psychiatric diagnosis for GID, hormone therapy, and sex reassignment surgery. For GID diagnosis, respondents answered the question, “Have you ever received a psychiatric diagnosis for GID based on the Korean Standard Classification of Diseases?” Those who did not seek a GID diagnosis were asked to report the reasons why, and multiple choices could be selected.
Hormone therapy was measured with the question, “Are you currently receiving hormone therapy?” Response options were: “I am currently receiving hormone therapy”; “I received hormone therapy, but not currently”; “I never receive hormone therapy, but I want to (or plan to) sometime later”; “I am not sure whether I want to receive hormone therapy”; or “I do not want to receive hormone therapy”. Respondents who chose “I am currently receiving hormone therapy” or “I received hormone therapy, but not currently” were classified as those having experienced hormone therapy, and they were asked to respond to a follow-up question about purchasing non-prescribed hormone medications. For those who have purchased non-prescribed hormone medications, they were asked to report the route of access and the reasons why. In addition, respondents who did not receive hormone therapy were asked to identify the reasons why. Multiple responses could be selected for the questions regarding the route of and the reasons for purchasing hormone medications without a prescription and the reasons for not receiving hormone therapy.
Regarding sex reassignment surgery, respondents were asked whether they have had at least one surgical procedure related to transition. For those who did not have such surgery, additional questions were asked about the reasons why, and multiple choices could be selected.
This study also measured the costs of GID diagnosis and sex reassignment surgery. Regarding the cost of GID diagnosis, respondents chose a response from 0 to 1 million KRW. Since the total cost of hormone therapy varies with the duration of partaking in the therapy, an average cost was not presented. Sex reassignment surgery was classified into breast/chest surgery, genital removal surgery, genital reconstruction surgery, facial surgery, voice surgery (only for transfeminine respondents), and other surgeries. For the cost of sex reassignment surgery, respondents responded from 1 to 50 million KRW, with suggestions of the average cost and standard deviation. Additionally, respondents reported their experiences of delaying or avoiding hospital visits and being denied healthcare services within the past 12 months.
Statistical analysis
This study analyzed the experiences and barriers that transgender people faced during transition-related healthcare with descriptive statistics, and the results were stratified by participants’ gender identity. All statistical analyses were performed using Stata/SE version 13.0 (StataCorp., College Station, TX, USA).
RESULTS
Socio-demographic characteristics and experiences of transition-related healthcare
Among the total study population, 173 (62.2%) were transfeminine and 105 (37.8%) were transmasculine. Of all respondents, 218 (78.4%) were 19-29 years and 60 (21.6%) were 30-50 years old, indicating that the majority were in their 20s (Table 2). Regarding sexual orientation and educational level, heterosexual (n=129/278, 46.4%) and university graduate (n=145/254, 57.1%) were the most frequent responses. Approximately half of respondents reported an annual household income of <10,000,000 (n=69/252, 27.4%) and 10,000,000-19,990,000 KRW (n=53/252, 21.0%). More than three-quarters of respondents were unemployed (n=118/253, 46.6%) or precarious employees (n=78/253, 30.8%), and a majority resided in metropolitan cities. Most respondents participated in the survey through four healthcare institutions (n=130/278, 46.8%) and online/offline transgender communities (n=126/278, 45.3%).
Among 278 transgender adults, 253 (91.0%) had been diagnosed with GID (Table 3). Meanwhile, 243 of 276 respondents (88.0%) who answered the question about hormone therapy were receiving or had previously received hormone therapy, and 115 of 271 respondents (42.4%) who answered the question about sex reassignment surgery have had at least one of transition-related surgery. The prevalence of a GID diagnosis was significantly higher in the transfeminine group (n=164/173, 94.8%) and 30-50-year-old group (n=59/60, 98.3%) than in the transmasculine group (n=89/105, 84.8%) and 19-29-year-old group (n=194/218, 89.0%). The prevalence of hormone therapy also was significantly higher in the transfeminine group (n=160/171, 93.6%) and 30-50-year-old group (n=58/59, 98.3%) than in the transmasculine group (n=83/105, 79.0%) and 19-29-year-old group (n=185/217, 85.3%). However, the prevalence of sex reassignment surgery was significantly higher in the transmasculine group (n=58/103, 56.3%) compared to the transfeminine group (n=57/168, 33.9%).
Barriers to transition-related healthcare
A majority of transfeminine (n=164/173, 94.8%) and transmasculine (n=89/105, 84.8%) individuals reported that they were diagnosed with GID (Table 4). Among these 25 individuals who did not receive a GID diagnosis, 12 (48.0%) answered, “I was having financial difficulties”.
Among 276 respondents, 225 (81.5%) reported that they were currently receiving hormone therapy (Table 5). In terms of gender identity, 150 of 171 transfeminine (87.7%) and 75 of 105 transmasculine (71.4%) individuals were currently receiving hormone therapy. Those who were not currently receiving hormone therapy (n=51/276, 18.5%) were asked about the reasons for not receiving or discontinuing the therapy, and the most common response was “I was having financial difficulties” (n=28/51, 54.9%).
Among the 243 respondents who had ever received hormone therapy, 61 (25.1%) reported that they had ever purchased non-prescribed hormone medications (Table 6). Those who had purchased non-prescribed hormone medications were asked about the purchasing route of such medications, and the most common response was “over-the-counter medicines” (n=28/61, 45.9%), which is similar to contraceptives. With respect to reasons for purchasing non-prescribed hormone medications, the most common response was “I did not have a diagnosis from a psychiatrist” (n=34/61, 55.7%).
A total of 115 among 271 transgender respondents reported that they had undergone at least one kind of sex reassignment surgery, including 57 of 168 transfeminine (33.9%) and 58 of 103 transmasculine (56.3%) individuals (Table 7). Among 271 respondents, 156 (57.6%) did not have any kind of sex reassignment surgery. The most common reason why they did not have such surgery was “The surgery was too costly” (n=122/156, 78.2%).
DISCUSSION
This study analyzed cross-sectional data of 278 transgender adults to investigate the experiences of and barriers to transition-related healthcare in Korea. The results suggest that 91.0% of surveyed transgender adults were diagnosed with GID, 88.0% had received hormone therapy, and 42.4% had undergone at least one kind of transition-related surgery. The primary reason for not accessing transition-related healthcare was due to the cost of such procedures. This study additionally analyzed the cost that participants paid for transition-related healthcare (Appendix 1). A majority (n=170, 67.7%) reported that they paid 250,000-490,000 KRW for a GID diagnosis. The average cost of each kind of sex reassignment surgery was calculated and classified by respondents’ gender identity. These results indicated that genital reconstruction surgery was the biggest financial burden for transgender respondents, estimated at an average of 15,148,000 KRW for transfeminine and 20,571,000 KRW for transmasculine individuals.
Along with the high costs of medical transition, prejudice and discrimination of healthcare professionals towards transgender individuals were primary factors limiting use of transition-related healthcare. This study further analyzed respondents’ experiences of delaying or avoiding hospital visits and being denied services by healthcare professionals (Appendix 2). Among 262 participants, 112 (42.7%) reported that they themselves had delayed or avoided hospital visits, and 14 (5.3%) reported that they were denied healthcare services within the past 12 months. According to a previous survey about discrimination based on sexual orientation and gender identity in Korea, 28 of 78 transgender respondents (35.9%) who visited healthcare institutions within the past 5 years reported that they experienced discrimination from healthcare professionals [18].
Another barrier to transition-related healthcare was based on the limited knowledge of healthcare professionals on medical transition and the lack of healthcare institutions that can provide such procedures. Among the 25 transgender participants who did not receive a GID diagnosis, 28.0% responded that “I could not find a psychiatrist who would provide an adequate diagnosis.” Since GID diagnosis is required to receive hormone therapy and sex reassignment surgery in the majority of cases, the diagnosis plays an essential role in determining access to medical transition [19]. Among respondents who did not receive hormone therapy, 33.3% reported a reason of “I did not have a medical certificate from a psychiatrist” and 15.7% reported a reason of “I did not have access to healthcare facilities that provided hormone therapy”.
The World Professional Association for Transgender Health has published “Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People,” providing a clinical guideline for transition-related healthcare [2]. In North American and European countries, education and training programs on medical transition for healthcare professionals have been developed in healthcare institutions and academic societies [7]. Moreover, previous studies indicate that educating and training medical students about transition-related healthcare strengthens their competency as healthcare professionals with respect to knowledge, attitude, and skills regarding transgender health [20,21]. Since Korean medical schools do not educate about medical transition, healthcare professionals have relatively little knowledge about such procedures [7].
Negative social perception towards transgender people was another barrier that may inhibit these individuals from accessing transition-related healthcare. Participants provided the following reasons for not receiving hormone therapy: “I believed it would raise difficulties in my economic activities such as finding employment and working” (47.1%), “I was worried about potential stigma from other people around me” (25.5%), and “My family and/or friends advised against it” (15.7%). Those who did not have sex reassignment surgery also responded with the following reasons: “I believed it would raise difficulties in my economic activities such as finding employment and working” (36.5%), “My family and/or friends advised against it” (25.0%), and “I was worried about potential stigma from other people around me” (20.5%). Transgender individuals could experience difficulties in economic activities, such as getting a job or maintaining a career, due to medical transition experiences. Further, family members and friends of transgender individuals may oppose their medical transition.
Our results indicate that transgender people encountered barriers to accessing transition-related healthcare due to financial burden, negative experiences in healthcare settings, lack of specialized healthcare professionals and medical facilities, and social stigma against transgender individuals in Korea. These barriers could contribute to unsafe practices regarding transition-related healthcare [22,23]. In this study, 25.1% of 243 transgender participants reported purchasing non-prescribed hormone medications. They used over-the-counter medicines that contained hormonal components or purchased hormone drugs through domestic or foreign online vendors/suppliers or acquaintances/friends. For patient safety, healthcare professionals should control the dose of hormone therapy depending on the health condition of the transgender individual, and regular clinical follow-ups also are essential in hormone therapy. Therefore, self-prescribed hormone medications can be hazardous because the side effects, such as thromboembolism or elevated liver enzymes, may not be identified or appropriately treated [7,23].
To improve access to transition-related healthcare for transgender populations, national health insurance coverage should be expanded for such procedures. Among 118 nations, 45 countries pay for the costs of at least one kind of medical transition through national health insurance or public healthcare system [7]. Currently, the Korean public healthcare system does not cover the costs of hormone therapy or sex reassignment surgery for transgender people. Considering that expanding health insurance coverage could be an institutional intervention to relieve the financial burden of transition-related healthcare, more active discussions on this topic should be facilitated.
A noteworthy limitation of this study is that respondents may not accurately represent the whole transgender population in Korea. However, the population size is unknown because no studies have identified the transgender population size as of May 2018 in Korea [7,16]. We tried to recruit the maximum number of transgender individuals from healthcare institutions, Korea Queer Culture Festivals, and online/offline transgender communities through convenience sampling. Nonetheless, such data collection strategies may influence and potentially bias the study’s findings. Among 278 transgender respondents, 46.8% participated through healthcare institutions, whereas 45.3 and 7.9% became involved through online/offline transgender communities and the Korea Queer Culture Festivals, respectively. The number of respondents from healthcare institutions who had received a GID diagnosis or hormone therapy was relatively higher than that of respondents from online/offline transgender communities and the Korea Queer Culture Festivals. We cannot exclude the possibility that the experiences of respondents from healthcare institutions who received a GID diagnosis or hormone therapy may be overrepresented. In addition, the majority of respondents (78.4%) were in their 20s, which may be attributed to use of an online-based survey. Consequently, the findings of this study should be cautiously interpreted.
Despite these limitations, the present study also has key strengths. First, this study included the largest number of transgender participants in Korea as of May 2018, since all available methods was fully utilized to collect data. Second, this is the first academic research to identify the experiences of and barriers to transition-related healthcare of Korean transgender adults. Considering our findings, future research should continue to examine the health of the transgender population in Korea.
In conclusion, transition-related healthcare is medically necessary for transgender individuals to alleviate their gender dysphoria. Also, it is a legal prerequisite to change their gender identity on official documents and a method to protect themselves against social violence and discrimination and to access sex-segregated facilities, such as public toilets [19]. Therefore, expansions of health insurance coverage to include medical transition is needed to improve access to such medical procedures and support the health of transgender people. In addition, education and training programs for healthcare professionals should be institutionalized to ensure that they can provide appropriate transition-related healthcare services to transgender people. Beyond the healthcare setting, additional discussions are needed to improve social acceptance and recognition of transgender population and reduce stigma and discrimination against them. We strongly recommend that government-conducted nationwide surveys should include questions about respondents’ gender identity to promote future research on the health of transgender people. Lastly, based on our findings about barriers to transition-related healthcare, implementation of institutional intervention is urgently required to improve the health of Korean transgender individuals.
PDF Links
Summary
PubReader
ePub Link
XML Download
Full text via DOI
Download Citation
CrossRef TDM
Download PPT
Print
